These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18274957)

  • 21. Combined use of irinotecan with histone deacetylase inhibitor belinostat could cause severe toxicity by inhibiting SN-38 glucuronidation via UGT1A1.
    Wang L; Chan CEL; Wong AL; Wong FC; Lim SW; Chinnathambi A; Alharbi SA; Lee LS; Soo R; Yong WP; Lee SC; Ho PC; Sethi G; Goh BC
    Oncotarget; 2017 Jun; 8(25):41572-41581. PubMed ID: 28157715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rat hepatocyte suspensions as a suitable in vitro model for studying the biotransformation of histone deacetylase inhibitors.
    Elaut G; Török G; Papeleu P; Vanhaecke T; Laus G; Tourwé D; Rogiers V
    Altern Lab Anim; 2004 Jun; 32 Suppl 1A():105-12. PubMed ID: 23577441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of 1'-hydroxymidazolam glucuronidation in human liver microsomes.
    Zhu B; Bush D; Doss GA; Vincent S; Franklin RB; Xu S
    Drug Metab Dispos; 2008 Feb; 36(2):331-8. PubMed ID: 17998299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Property based optimization of δ-lactam HDAC inhibitors for metabolic stability.
    Yoon HC; Choi E; Park JE; Cho M; Seo JJ; Oh SJ; Kang JS; Kim HM; Park SK; Lee K; Han G
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6808-11. PubMed ID: 20850971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of human CYP2A6 and rat CYP2B1 in the oxidation of (+)-fenchol by liver microsomes.
    Miyazawa M; Gyoubu K
    Xenobiotica; 2007 Sep; 37(9):943-53. PubMed ID: 17992728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of cytochrome P450 2E1 in the species-dependent biotransformation of 1,2-dichloro-1,1,2-trifluoroethane in rats and mice.
    Dekant W; Assmann M; Urban G
    Toxicol Appl Pharmacol; 1995 Dec; 135(2):200-7. PubMed ID: 8545828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the metabolism of sibiricaxanthone F and its aglycone in vitro by high performance liquid chromatography coupled with Q-trap mass spectrometry.
    Song Y; Yang X; Jiang Y; Tu P
    J Pharm Biomed Anal; 2012 Nov; 70():700-7. PubMed ID: 22819207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro studies on the metabolic activation of the furanopyridine L-754,394, a highly potent and selective mechanism-based inhibitor of cytochrome P450 3A4.
    Sahali-Sahly Y; Balani SK; Lin JH; Baillie TA
    Chem Res Toxicol; 1996 Sep; 9(6):1007-12. PubMed ID: 8870989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of human liver cytochrome P450 enzymes that metabolize the nonsedating antihistamine loratadine. Formation of descarboethoxyloratadine by CYP3A4 and CYP2D6.
    Yumibe N; Huie K; Chen KJ; Snow M; Clement RP; Cayen MN
    Biochem Pharmacol; 1996 Jan; 51(2):165-72. PubMed ID: 8615885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro characterization of 4'-(p-toluenesulfonylamide)-4-hydroxychalcone using human liver microsomes and recombinant cytochrome P450s.
    Lee B; Wu Z; Lee T; Tan XF; Park KH; Liu KH
    Xenobiotica; 2016; 46(4):350-6. PubMed ID: 26330107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparations.
    Egorin MJ; Rosen DM; Wolff JH; Callery PS; Musser SM; Eiseman JL
    Cancer Res; 1998 Jun; 58(11):2385-96. PubMed ID: 9622079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetic characteristics of norcocaine N-hydroxylation in mouse and human liver microsomes: involvement of CYP enzymes.
    Pellinen P; Kulmala L; Konttila J; Auriola S; Pasanen M; Juvonen R
    Arch Toxicol; 2000 Nov; 74(9):511-20. PubMed ID: 11131030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of enzymes responsible for rifalazil metabolism in human liver microsomes.
    Mae T; Inaba T; Konishi E; Hosoe K; Hidaka T
    Xenobiotica; 2000 Jun; 30(6):565-74. PubMed ID: 10923859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidation of 1,2-epoxy-3-butene to 1,2:3,4-diepoxybutane by cDNA-expressed human cytochromes P450 2E1 and 3A4 and human, mouse and rat liver microsomes.
    Seaton MJ; Follansbee MH; Bond JA
    Carcinogenesis; 1995 Oct; 16(10):2287-93. PubMed ID: 7586124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lactam based 7-amino suberoylamide hydroxamic acids as potent HDAC inhibitors.
    Taddei M; Cini E; Giannotti L; Giannini G; Battistuzzi G; Vignola D; Vesci L; Cabri W
    Bioorg Med Chem Lett; 2014 Jan; 24(1):61-4. PubMed ID: 24345446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism distribution and excretion of a matrix metalloproteinase-13 inhibitor, 4-[4-(4-fluorophenoxy)-benzenesulfonylamino]tetrahydropyran-4-carboxylic acid hydroxyamide (CP-544439), in rats and dogs: assessment of the metabolic profile of CP-544439 in plasma and urine of humans.
    Dalvie D; Cosker T; Boyden T; Zhou S; Schroeder C; Potchoiba MJ
    Drug Metab Dispos; 2008 Sep; 36(9):1869-83. PubMed ID: 18566038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of cadmium-decreased glucuronidation in the rat.
    Alary J; Cravedi JP; Baradat M; Carrera G
    Biochem Pharmacol; 1992 Dec; 44(11):2139-47. PubMed ID: 1472079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural characterization of anti-HIV drug candidate PA-457 [3-O-(3',3'-dimethylsuccinyl)-betulinic acid] and its acyl glucuronides in rat bile and evaluation of in vitro stability in human and animal liver microsomes and plasma.
    Wen Z; Stern ST; Martin DE; Lee KH; Smith PC
    Drug Metab Dispos; 2006 Sep; 34(9):1436-42. PubMed ID: 16751262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro biotransformation of a novel antimalarial cysteine protease inhibitor in human liver microsomes.
    Zhang Y; Guo X; Lin ET; Benet LZ
    Pharmacology; 1999 Mar; 58(3):147-59. PubMed ID: 9925971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro glucuronidation of the cyclin-dependent kinase inhibitor flavopiridol by rat and human liver microsomes: involvement of UDP-glucuronosyltransferases 1A1 and 1A9.
    Hagenauer B; Salamon A; Thalhammer T; Kunert O; Haslinger E; Klingler P; Senderowicz AM; Sausville EA; Jäger W
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):407-14. PubMed ID: 11259324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.